248 results
8-K
EX-99.1
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
securities laws, including the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E
8-K
EX-99.2
RGEN
Repligen Corp.
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
, including the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
8-K
EX-99.1
m4hc z6flmjsg
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
EX-10.1
5fioe87j7z ve
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-99.1
h07r6wmt lzuys
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
EX-99.1
acghihfbkp
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
svxc hvn59ukl
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am
8-K
EX-10.2
rohhc0p
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
EX-99.1
fm4tdvm qh5dkb94
27 Apr 22
Repligen Reports First Quarter 2022 Financial Results
7:47am
8-K
EX-99.1
ygb07um 18ce1rrcm
17 Feb 22
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
7:49am